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Abstract 
Background: Marginal structural models (MSMs) are commonly used to estimate causal intervention 
effects in longitudinal non-randomised studies. A common issue when analysing data from 
observational studies is the presence of incomplete confounder data, which might lead to bias in the 
intervention effect estimates if they are not handled properly in the statistical analysis. However, 
there is currently no recommendation on how to address missing data on covariates in MSMs under 
a variety of missingness mechanisms encountered in practice. 
Methods: We reviewed existing methods to handling missing data in MSMs and performed a 
simulation study to compare the performance of complete case (CC) analysis, the last observation 
carried forward (LOCF), the missingness pattern approach (MPA), multiple imputation (MI) and 
inverse-probability-of-missingness weighting (IPMW). We generated data in which the covariates and 
treatment were measured at three time-points and a continuous outcome was measured at the end 
of follow-up. Two covariates were partially observed. We considered three mechanisms for non-
monotone missing data which are common in observational studies using electronic health record 
data. We illustrated the strengths and limitations of these analysis methods through an application to 
observational data looking at the causal effect of observance to continuous positive airway pressure 
device on sleepiness symptoms among patients with sleep apnoea. 
Results: Whereas CC analysis lead to biased estimates of the intervention effect in almost all scenarios, 
the performance of the other approaches varied across scenarios. The LOCF approach led to unbiased 
estimates only under a specific non-random mechanism in which confounder values were missing 
when their values remained unchanged since the previous measurement. In this scenario, MI, the 
MPA and IPMW were biased. MI and IPMW led to the estimation of unbiased effects when data were 
missing at random, given the covariates or the treatment but only MI was unbiased when the outcome 
was a predictor of missingness. Furthermore, IPMW generally lead to very large standard errors. 
Lastly, regardless of the missingness mechanism, the MPA led to unbiased estimates only when the 
failure to record a confounder at a given time-point modified the subsequent relationships between 
the partially observed covariate and the outcome. 
Conclusions: The choice of the appropriate method(s) to handle partially observed confounders when 
using MSMs must rely on a careful consideration of the reasons for missingness and whether 
missingness modifies the existing relationships among observed data. This choice also depends on the 
scientific context and the data source. Sensitivity analyses should be performed to assess the 
robustness of the results to departures from the postulated missingness mechanisms. 
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 1. Introduction 
Although randomised trials are often considered as the gold standard to establish causal effects of 
treatments and non-pharmacological interventions on health outcomes, the use of observational data 
for causal inference has been continuously increasing in the past 30 years (1). The enormous potential 
offered by the wealth of routinely collected medical data already available and the need for real-world 
evidence to assess the efficacy and safety of treatments have contributed to this phenomenon.  
These routinely collected data have typically a longitudinal structure, as individuals are followed up 
over time, which allows the measurement of dynamic treatment patterns, including treatment 
switching or delay to treatment initiation. For instance, patients with chronic conditions often have a 
non-linear treatment history: treatment prescription might be updated based on the occurrence of 
new health events, changes in individual factors or side-effects induced by previous treatments. The 
newly prescribed treatment might, in turn, affect future health events and individual factors, 
themselves potentially associated with the outcome of interest (2). In such settings, specific statistical 
methods are required to account for confounding bias induced by time-varying variables (3).  
In epidemiology, multivariable regression (4) and propensity scores (5,6) are often used to address 
confounding. When neither treatment nor confounders are time-varying multivariable regression can 
appropriately account for confounding and lead to an unbiased estimate of the (conditional) causal 
effect of the treatment. However, with time-varying treatment and confounders, adjusting for the 
confounders and treatment history is not sufficient, and often leads to biased estimates of the causal 
treatment effects (7). This is because the effect of a treatment received at a specific time on the 
outcome is mediated by subsequent treatments. On the other hand, propensity scores - defined as 
the individual probabilities of receiving the treatment of interest conditionally on individual 
characteristics - have been extended to situations with time-varying treatment and confounders (8), 
with scores estimated at each time-point (9).  The cumulative product of the inverse of these scores 
over time can be used as a weight to account for confounding in the estimation of the treatment effect 
in a marginal structural model (MSM) (10). This method is by far the most common method to adjust 
for time-varying confounders in practice, followed by g-computation (11). 
However, a common challenge in the statistical analysis of observational data is incomplete 
confounder information. In routinely collected data (e.g. from primary care), missing data may occur 
on treatments and outcomes but is particularly prevalent on covariates. This can happen if some 
information is not recorded at a given time-point or when the frequency of the measurement varies 
from one patient to another (e.g. asynchronous visits at the general practice (12)). The risk of missing 
confounder values usually increases with the number of time-points. This might jeopardize the validity 
of the results if the issue is ignored in the analysis, depending on the underlying missingness 
mechanisms. In practice, despite the STROBE recommendations to report the amount of missing data 
and the way they are handled (13) in observational studies, reporting is often suboptimal. A review 
looking at the reporting of missing exposure data in a longitudinal cohort showed that 43% of 
identified publications adhered to these guidelines (14). More importantly, when the method for 
handling missing data was reported, it was often done using inadequate methods. Although a variety 
of methods to handle missing data on covariates have been used in the context of time-varying 
exposures (14), the most common approaches – complete case (CC) analysis and last observation 
carried forward (LOCF) – have been criticized. The use of more complex approaches such as multiple 
imputation (MI) or inverse-probability of-missingness-weighting (IPMW) have been suggested, but the 
their performance is yet to be explored in a wider range of plausible missingness mechanisms. Another 
promising approach, which has not been extended to the context of MSMs, is the missingness pattern 
approach (MPA). 
To our knowledge, there are no published guidelines for the choice of methods to handle missing 
confounder data in MSMs, and approaches used in simpler settings have not been investigated jointly 
with the use of MSMs. Published studies on missing data in MSMs focused on missing data in the 
exposure (14,15) or compared the performances of a few methods only (16,17). Moodie et al. (17) 
compared the use of IMPW and MI, showing that MI systematically outperformed IPMW, but they did 
not investigate the relative performance of the MPA and LOCF. Moreover, only one covariate and two 
time-points were generated in their simulation study, limiting the generalisability of the results. Vourli 
and Touloumi (18) investigated the performance of MI, IPMW and LOCF but found opposite 
conclusions in their setting, and showed that IPMW usually performed better than MI. This result 
might be explained by the omission of the outcome from the imputation model. A recent plasmode 
simulation (16) suggested superiority of MI over IPMW, but surprisingly, in their settings, CC analysis 
was the least biased. Furthermore, missingness mechanisms commonly studied in the literature (18) 
are those classically described under Rubin’s taxonomy of missing data (19), but this taxonomy may 
be too restrictive to describe complex missingness scenarios encountered in routinely collected data 
(20). Therefore, the aim of this paper is to provide an overview of existing methods followed with 
practical guidelines to handle missing data on confounders in MSMs. These guidelines will rely on the 
understanding of the assumptions and missingness mechanisms under which these methods are valid. 
We will also present a simulation study comparing the performance of CC analysis, LOCF, MI, IPMW 
and MPA to handle partially observed confounders under three common missingness mechanisms 
encountered in observational studies.  
The paper is organised as follows: Section 2 describes the use of MSMs. The issue of missing data and 
the available methods are discussed in Section 3. Section 4 and 5 present the design and the results 
of a simulation study, aiming to empirically evaluate the performance of CC analysis, LOCF, MI, IPMW 
and MPA to estimate the causal effect of a time-varying binary treatment on a continuous outcome. 
An illustrative example looking at the impact of the observance to treatment on sleepiness in patients 
with sleep apnoea is presented in Section 6, followed by a discussion (Section 7). 
 
2. Causal inference in presence of time-varying treatment and confounders 
In the presence of time-varying confounding, standard regression approaches fail because of 
treatment-confounder feedback (21), even when past treatment and confounders values are adjusted 
for (3). Robins (10) developed a new class of models (MSMs) to estimate causal effects in this setting. 
MSMs rely on an extension of inverse-probability-of-treatment weighting (IPTW) for more than one 
time-point within the potential outcomes framework. Details about this framework and the 
underlying assumptions for a single time-point can be found in Appendix A1. Similar to propensity 
score approaches, MSMs are a two-stage process. In the first stage, (21), weights – based on the 
inverse of the probability of a patient receiving the treatment they actually received – are estimated 
to create a pseudo-population in which the treatment is independent of the confounders. In the 
second stage, a weighted regression (using the weights derived in the first stage) including only the 
treatment history can be used to obtain estimate the causal effect of the treatment regimens of 
interest. Under the assumptions of no interference, consistency, exchangeability and positivity 
extended to time-varying settings and assuming the model used to obtain the weights is correctly 
specified, MSMs lead to unbiased estimates of the marginal causal effect of the treatment regimen.  
In practice, the weights can be estimated using pooled logistic regression (9), in which each person-
time interval is considered as an observation. This pooled logistic regression model must include the 
confounders and their relevant interactions to ensure the distributions of confounders are balanced 
between treatment groups in the weighted pseudo-population at each time-point. Further details 
about the implementation of MSMs can be found in Appendix A2. 
 
3. Missing data in MSMs 
 
3.1. Missingness patterns and missingness mechanisms in longitudinal studies 
The choice of an appropriate procedure for addressing missing data relies on the characterization of 
the missingness patterns in the data and the missingness mechanisms. The missingness patterns are 
all the possible arrangements of missing and observed values in the data. In longitudinal studies, three 
types of missingness patterns are usually described. The first is a univariate pattern where only one 
variable has missing data. The second type is monotone missingness which occurs when, once a 
patient has a missing observation at one time-point, values for all subsequent time-points are also 
missing. The third general pattern of missingness is arbitrary (or intermittent) missingness in which 
there is no specific structure for the measurements and patients with missing values. These patterns 
relate to the different ways in which missing data occurs in longitudinal studies. If patients are lost to 
follow-up, their exposure, covariates and outcome are completely missing at a specific time-point and 
onwards, corresponding to monotone missingness. Sparse follow-up is another context in which 
exposure, covariates and outcome can be fully missing, but unlike loss-to-follow-up, this missingness 
pattern is not monotone. In this paper, we focus on this third situation, as there is little guidance in 
the literature on the best statistical method to tackle this problem. This is also the most common 
pattern found in routinely collected data where data are not collected for a research purpose, where 
the quality of recording may vary from one visit to another. 
Little and Rubin’s classification is often used to classify the missing data as being (i) missing completely 
at random (MCAR) when the probability of data being missing does not depend on the observed or 
unobserved data, (ii) missing at random (MAR) if the probability of data being missing does not depend 
on the unobserved data, conditional on the observed data or (iii) missing not at random (MNAR) if the 
probability of data being missing depends on the unobserved data, even after conditioning on the 
observed data (22). The next section presents five methods for addressing missing confounder values 
in MSMs and relates their validity to the underlying missingness mechanism. 
3.2. Missing data methods 
 
3.2.1. Complete case analysis 
Complete case (CC) analysis is a straightforward and widely used approach to handle missing data in 
MSMs. In CC analysis, the parameters of the MSM are estimated from the sub-sample of patients with 
a complete record for all the variables and for all time-points (17). The first limitation of this approach 
is a loss in sample size, which may affect the precision of the estimates. The second, – and more 
problematic – limitation, is the risk of invalid inference following its use. In standard regression 
modelling, CC analysis can allow the estimation of unbiased conditional estimates of the treatment 
effect provided that the probability of being a complete case is independent of the outcome (23). The 
validity of CC analysis to estimate marginal effects relies on the stronger assumption that missing data 
are MCAR (24). This assumption is rarely plausible, and its violations can usually be demonstrated 
using the observed data.  
3.2.2. Multiple imputation 
The general principle of MI is to generate multiple sets of plausible values for the missing observations 
by drawing from the posterior predictive distribution of these variables given the observed data. This 
leads to the generation of M complete datasets, which are then analysed independently to produce 
M estimates of the regression coefficients of the MSM. These estimates are then combined across the 
M imputed datasets following Rubin’s rules to obtain an overall estimate and its variance, as described 
in Appendix A2.  
MI can provide valid inference if the data are MAR, regardless of the role of variables predictive of 
missingness in the analysis model (i.e. treatment, outcome or confounder). Unfortunately, the 
extensions of MI to accommodate data under MNAR mechanisms are limited (25). In addition, a 
correct specification of the imputation model is key to obtain valid inference after MI of the covariates. 
Critically, even when MI is used to handle missing values in confounder data, the outcome must be 
included in the imputation model in order to preserve the existing relationships between the variables 
and the outcome (26). Furthermore, in longitudinal studies, it has been recommended to include all 
the covariate measurements in the model as well as the full treatment history. In doing so, several 
measurements of the same variable are seen as independent variables, preserving the correlation 
between subsequent measurements. However, convergence problems may arise because of 
overfitting when the number of time-points is large in comparison to the total sample size (27). 
Providing that factors associated with missingness are measured and the imputation model is correctly 
specified, MI may lead to unbiased estimates of the treatment effect (17) estimated from MSMs. 
3.2.3. The missingness pattern approach 
The missingness pattern approach (MPA) is a method proposed to handle missing data in the specific 
context of propensity-score analysis, including IPTW (28,29). This approach involves splitting the 
analysis sample into subsamples based on their missingness pattern. Then, the weight models are 
estimated separately within each pattern using only the variables fully observed in that pattern. When 
using IPTW with a single time-point, the MPA can lead to the estimation of unbiased treatment effects 
under a set of assumptions which are not dependent on the missingness mechanism itself but rather 
on the existing relationships between the true (but unobserved) values of the confounders and the 
treatment and outcome (20,30). The first assumption is the absence of unmeasured confounding 
within each missingness pattern (which is the conditional exchangeability assumption introduced in 
Section 2.1 within each pattern). In addition, the MPA requires that the partially observed covariate is 
no longer a confounder once missing (for more details, see (20)). Because of the peculiarity of these 
assumptions, the MPA may be valid under some MNAR mechanisms but biased under some MCAR 
mechanisms. To our knowledge, this approach has not been extended yet to time-varying IPTW for 
MSMs, but might exhibit good performances providing the aforementioned assumptions hold at each 
time-point.  
3.2.4. The Last observation carried forward 
Due to its simplicity, the last observation carried forward (LOCF) is another popular approach for 
handling missing data in studies with repeated measurements.  LOCF is a form of single imputation, in 
which a missing covariate value is replaced by the most recent value recorded for that covariate for 
the same patient. The LOCF approach requires a complete measurement of the baseline data, because 
no prior information would be available to impute the first value. However, the main limitation of this 
approach is that its validity relies on the strong assumption that (i) either the true (but unobserved) 
distribution of the missing values at a given time point is exactly the same as the distribution of the 
observations used for the imputation (31) or (ii) when a value is missing, the treatment decision 
depends on the previous available measurement rather than the true (unobserved) one (32). In the 
first situation, LOCF is valid when the reason for missingness is the absence of change in values 
between two subsequent measurements. For instance, in routinely collected primary care data, a 
patient who is recorded as a non-smoker may not have smoking behaviour re-recorded unless they 
report a change (i.e. that they have started smoking). This is a very peculiar form of MNAR mechanisms 
where the associations between the missing confounder value and the previous observed value is 
deterministic. The second situation may also occur in routinely collected primary care data: general 
practitioners may base the treatment decision on the last available test results if the most recent 
results are not yet available. In the implementation of the LOCF approach, the uncertainty surrounding 
the imputation of missing values is not accounted for, leading to a potential underestimation of the 
variance of the treatment effect estimates, and therefore to an inflation of the type I error rate (33). 
MI can account for the uncertainty in the imputation but standard implementations of MI make the 
MAR assumption, so do not provide a direct alternative to LOCF when data follow this specific 
missingness mechanism. 
3.2.5. Inverse-probability-of-missingness weighting 
In MSMs, Robins and Hernán (10) proposed the use of censoring weights to account for patients lost 
to follow-up. Complete cases are re-weighted by the inverse of their probability of remaining in the 
study. Loss to follow-up can be viewed as a missing data problem, and therefore, these weights can 
be accommodated to account for missing data in an approach called inverse-probability-of-
missingness weighting (IPMW). The main difference is that loss to follow-up will generate monotone 
missing data, that is, if data is missing at a given time-point, it will be missing for all subsequent time-
points, whereas in MSMs, missing data are often sporadically missing. IPMW is very similar to IPTW 
introduced in section 2. Whereas IPTW aims to account for confounding by balancing the 
characteristics of treated and untreated patients, IPMW aims to additionally balance the 
characteristics of complete cases and incomplete cases (34). It thus involves the estimation of two sets 
of weights: treatment weights and missingness weights (see Appendix A3 for more details). The overall 
weight (i.e. the product of the weights of being treated and being a complete case) simultaneously 
deals with confounding and missing data. This approach was initially introduced in MSMs in the 
presence of loss to follow-up (10), meaning that, in our context of arbitrary missingness patterns, 
patients are censored once they have a missing confounder value, even when subsequent values are 
measured. Therefore, IPMW does not make use of all the information available, which can make it an 
inefficient technique for small to moderate sample sizes.  However, IPMW might be preferred over MI 
when patients with missing data tend to have missing values on many, rather than just one or two, 
variables, as it is often the case in observational studies (34). 
The missingness mechanisms encountered in electronic health records are often different from typical 
mechanisms observed in trials or observational cohorts created for research. Some of the ad hoc 
missing data methods presented above could be particularly useful for MSM analyses in this context. 
 
4. Methods 
We performed a simulation study to (i) illustrate the impact on bias of violations of the assumptions 
required for each method to be valid, and the relative precision of these methods when the 
assumptions hold and (ii) highlight existing challenges in their implementation in practice. Data were 
simulated to mimic an observational study, looking at the effect of a time-varying binary treatment 
on a continuous outcome, in the presence of time-varying confounding. Figure 1 presents a causal 
diagram illustrating the association between simulated variables. We focused on four plausible types 
of missingness mechanisms, illustrated in Figure 2- 3: 
- MCAR mechanism: missingness is not dependent on either observed or unobserved variables 
- MAR mechanism: we consider 3 situations in which missing data depends on observed past 
treatment and confounder values (MAR|A,L), past treatment and confounder values and 
outcome (MAR|A,L,Y) or considering an association between missingness and the outcome 
introduced through the independent risk factor (MAR|A,L,V). 
- “Constant” mechanism: confounder values are missing if they have remained constant since 
the last visit. This is one of the mechanisms under which LOCF is expected to perform well.  
- “Differential” mechanism: the missingness mechanism itself is MAR, but missingness affects 
the subsequent association between the true value of the confounder, and the treatment. 
This is the mechanism implicitly assumed when using the MPA.  
We compared the performance of CC analysis, LOCF, MPA, MI and IPMW to estimate the causal effect 
of the intervention at each time-point. The data-generating mechanisms, methods, estimands and 
performance measures for our simulations are presented in Appendix A4. 
 
5. Results 
Table 1 presents the scenarios for which each method can provide unbiased estimates of the 
treatment effects. The results of our simulation studies are presented as boxplots, showing the 
distribution of the absolute bias for each method. Full results are presented in Appendix (Tables A1 to 
A5). Note that even without missing data, if time-varying confounders are not accounted properly, the 
treatment effect estimates are strongly biased (Table A1).  
5.1. Missingness completely at random 
Whereas, CC, MI and IPMW lead to unbiased estimates at the three-time-points, the MPA estimates 
are biased at each time-point and LOCF estimates are biased at times 1 and 2 (Figure 3). The bias for 
the MPA arises from the direct associations existing between the confounders and the treatment 
allocation at subsequent time-points even among participants with missing covariate values. For LOCF, 
the bias arises because the missing values were generally different from the observed previous value 
because confounder values were affected by prior treatment. Among the unbiased approaches, MI 
had the best precision. The loss in efficiency for CC is explained by the loss in sample size (going from 
10,000 to 4,096). For IPMW, this loss is explained both by the same loss in sample size but also because 
of additional random variability introduced by the estimation of two independent sets of weights. 
5.2. Missingness at random 
Except MI, which led to unbiased estimates at each time-point for the three MAR scenarios, the 
performance of the other analysis strategies relied on the variables that were predictive of 
missingness (Figure 4). When missingness depended on the values of past treatment assignment and 
confounders, IPMW estimates were unbiased at the three time-points. A small bias was observed for 
complete case analysis and larger biases were obtained when using LOCF and MPA, for similar reasons 
as in MCAR scenarios. When the outcome was directly related to missingness, the only unbiased 
approached was MI. The bias of the treatment effect for all the other approaches was very large at 
the three time-points. However, when an indirect association between the outcome and missingness 
existed through a measured risk factor, the IPMW led to unbiased estimates, but with a lower 
precision than MI.  
5.3. Missingness on constant values 
When missing confounder values were missing when they remained constant, only LOCF allowed the 
estimation of unbiased treatment effect estimates (Figure 3). In that situation, the bias was worse 
with the use of MI and IPMW than with CC. This is because both MI and IPMW uses the existing 
relationships between the confounders, treatment and outcome among the participants with fully 
observed data, but in this scenario, these relationships do not reflect the associations existing 
between the true (but missing) confounders values and the other variables.  
5.4. Missingness affecting the subsequent covariate-treatment associations 
In this last scenario, MPA was the only appropriate method to obtain unbiased treatment effect 
estimates, although the bias observed for the other approaches is quite small. As in the previous 
scenario, the associations between confounders and treatment among the complete cases cannot be 
used to make inferences about the relationship among participant with missing confounder values. 
Therefore, CC, MI and IPMW are biased. LOCF does not lead to valid estimates either, because 
missingness depends on past treatment and confounder values, which induces missingness whatever 
the previous measurement value was. 
 
6. Illustrative example 
We used the data from a prospective national cohort, using the research database of the 
“Observatoire Sommeil de la Fédération de Pneumologie” (OSFP). The OSFP registry is a standardized 
web-based report, administered by the French Federation of Pulmonology and containing anonymized 
longitudinal data from patients with sleep disorders (35). We aimed to estimate the causal effect of 
compliance in the use of continuous positive airway pressure (CPAP) device on sleepiness symptoms 
among patients diagnosed with obstructive sleep apnoea. This device is a pump which delivers a 
continuous supply of air through a mask patients use overnight. In the OSFP registries, the number of 
recorded visits per patient varies, so for simplicity, we focused on patients who had a visit within 3 
months, 6 months and 1 year following the initiation of CPAP treatment. The observance was 
determined as an average use of CPAP >4hours per night within each time interval. The outcome was 
a continuous sleepiness score measured during the last visit using the Epworth Sleepiness Scale. Age, 
sex, body mass index (BMI), urination frequency per night and presence of depression were 
considered as potential confounders in this study. BMI, frequency of urination and depression were 
recorded at each visit but were partially observed. Patients’ characteristics are described in Appendix 
(Table A6). 
Out of 1169 included patients, only 266 (22.8%) patients had a complete record. Data is not MCAR 
since significant associations were observed between all the potential confounders and the probability 
of having a complete record. However, a MAR mechanism is plausible in this setting. The MPA is not 
a suitable method for this analysis because of missing data on the exposure that can be handled with 
the other approaches (CC, LOCF, MI and IPMW). These approaches were implemented in the same 
way as in our simulation study. 95% confidence intervals were computed using non-parametric 
bootstrap. 
The results are presented in Figure 5 and in Table A7. Overall, these results show no effect of CPAP 
compliance on sleepiness. As expected because of the relatively small sample size, IPMW led to very 
wide 95% confidence intervals. The 95% CI for LOCF is narrower, but it does not account for the 
uncertainty around the imputed values. Furthermore, the assumption underlying the validity of LOCF 
is unlikely to hold in this context. As expected, the approaches gave similar results because 
confounding was not very strong (Table A6). However, it illustrates the inefficiency of IPMW and the 
limitations of the MPA approach when there are missing data on the exposure.  
7. Discussion 
In this paper we presented five methods to handle missing values in partially observed time-varying 
covariates in MSMs and identified situations in which they are appropriate to estimate unbiased 
causal treatment effects. We also illustrated how to implement these approaches in practice, using 
data from the OSPF registry. We showed that, for the estimation of causal effects, CC analysis is often 
biased, unless data are missing completely at random. The validity of this assumption cannot be tested 
from the data (36) but violations of these assumptions can be detected by looking at associations 
between the probability of being a complete case and the variables available in the dataset, including 
the treatment and the outcome. While the missing completely at random assumption is rarely 
plausible in practice, we also showed that when missing values are missing at random given treatment 
history and confounder values, the bias of the CC estimates is usually small.  
LOCF, which is also widely used to handle missing data on time-varying variables leads to biased 
estimations of the treatment effects, unless missing values are in truth missing because they remained 
constant over time or when the previous measurement is used to adapt treatment (rather than the 
true - but missing - measurement). This is a particular case of MNAR mechanism. This assumption may 
hold in routinely collected data. For instance, GPs might not record a patient’s weight during a visit if 
it has not changed since the previous consultation. This assumption cannot be tested from the data 
but the plausibility of the assumption can be assessed using expert opinion, building on what has been 
proposed in randomised trials (37). Moreover, when using LOCF, the uncertainty around the single 
imputation of missing values is not accounted for (24). Although this is not an issue for categorical 
variables, this is problematic for continuous confounders where imputing exactly the previous 
measurement leads to inappropriate certainty, which might affect the validity of the inference made 
with too narrow confidence intervals. 
As expected, MI led to unbiased estimates of the treatment effect when data were MCAR or MAR. 
When implementing MI, the outcome must be included in the imputation model and the treatment 
effect estimated in each imputed dataset and combined using Rubin’s rules, as recommended in 
simpler settings with a single time-point (38). In our simulation study and illustrative example, 
treatment and covariate values for all the three time-points were included in the imputation model. 
With an increasing number of time-points, issues of overfitting may arise. Two-fold multiple 
imputation has been proposed to circumvent this problem (39). Instead of using all the time-blocks in 
the imputation model, only the current and adjacent times are used in addition to the outcome, and 
therefore fewer parameters are to be estimated in the imputation model. This approach showed good 
performance in the analysis of longitudinal electronic health records (27) even when the partially 
observed variable has a non-linear association with time (40).  
MPA and IPMW have never been investigated in the context of MSMs. The MPA is unbiased when 
either the association between the partially observed confounder and the outcome or between the 
partially observed confounder and the subsequent treatment disappears among patients with a 
missing value for that confounder. Hence, the validity of this approach does not depend on the 
missingness mechanism but instead the relationship between covariates, treatment and outcome 
among patients with missing data. One situation in which the MPA is thought to be useful is in the 
analysis of routinely collected data in which treatment prescription depends on biological test results. 
If these results are missing (i.e. the test is not done for that patient), physicians cannot use the test 
value in their treatment decision, which removes the association between the true value of biological 
parameter (which is unknown) and the subsequent treatment. The MPA is straightforward to 
implement but issues may arise when there are many missingness patterns. Furthermore, unlike MI, 
the MPA cannot accommodate missing data on the treatment and the outcome, which might limit its 
applicability.  IPMW, on the other hand, can handle missing data on any of the covariates, treatment 
or outcome, as it includes only the complete records in the analysis, regardless which variables 
(outcome, treatment or covariates) have missing values. IPMW leads to unbiased estimates when data 
is MCAR and MAR, unless missingness is directly affected by the outcome, because the outcome might 
be associated with treatment and confounder values at later time-points, which are not accounted for 
in the missingness model to compute the weights. IPMW is also unbiased in scenarios where the MPA 
is unbiased as well because patients are censored at the first missing data, and therefore, no use is 
made of the information measured at later time-points. However, IPMW is somewhat inefficient. This 
is explained firstly by a loss in sample size loss since only complete cases are analysed (34). Secondly, 
IPMW involves the multiplication of two weights (the treatment weight and the missingness weight) 
that are both estimated with uncertainty, leading to highly variable treatment effect estimates. 
However, the sample size in the simulation study and the illustrative example was moderate, so we 
recommend the use of IPMW in very large datasets, a situation in which MI would be highly 
computationally intensive. Furthermore, a limitation in the current implementation of IPMW is that 
missing data were considered as being monotone, that is, patents were excluded from the analysis 
even when some (or all) the information was available at the end of follow-up, including the outcome. 
Recent developments on inverse weighting for missing data have included an extension to non-
monotone missingness patterns (41), but it remains unclear how it could be transposed to MSMs. 
It is clear that there is no single missing data method able to simultaneously handle different types of 
missingness mechanisms. However, in practice, missing values can occur on several variables 
according to different mechanisms. In such situations, it is crucial to understand the reasons for 
missingness to identify groups of variables with similar missingness mechanisms that could be handled 
altogether. For instance, in routinely collected data, some variables might not have been updated 
because their values remained unchanged, and some variables might be missing at random. A 
pragmatic approach would be to first use the LOCF on the first group of variables, and then multiply 
impute the variables from the second group. A more principled combination of methods has been 
proposed in simpler settings. Qu and Lipkovich (42) combined the MPA and MI for propensity score 
analysis with a single time point. Seaman and White proposed to combine MI and IPMW (43) but 
further investigation is needed before implementing these methods in the context of MSMs. 
This paper has several limitations. First, we focused on a continuous outcome measured at the end of 
follow-up. However, our conclusions can be applied more broadly to binary and time-to-event 
outcomes, since the validity of CC, LOCF, MI, MPA and IPMW relies on the missingness mechanism 
which is independent of the nature of the outcome. Similar conclusions would also hold had the 
outcome been measured at each time-point. With repeated outcomes, however, intra-subject 
correlation must be accounting for in the outcome model, using for instance a sandwich variance 
estimator in the context of generalized estimated equations (44). Second, we considered a limited 
number of partially observed confounders in our simulation study. With a larger number of variables, 
the MPA approach might reach its limits in case of sparse data in some patterns of missingness. 
Moreover, in the presence of numerous variables with potential interactions and non-linear effects, 
the functional form of the weight model might be harder to specify parametrically, and the obtained 
weights can be very unstable. This can be improved using the robust methods proposed by Imai and 
Ratkovic (45). Alternatively, statistical learning methods might be a promising alternative to pooled 
logistic regression in such settings (46). Third, we acknowledge that the standard error of the 
treatment effect estimates in the simulation study did not account for the uncertainty in the 
estimations of the weights, which lead to 95% confidence intervals that were too large. A variance 
estimator accounting for this uncertainty has been proposed in the context of propensity score 
weighting (47) but has yet to be extended to the MSM context. Non-parametric bootstrap was used 
in our illustrative example but was unfortunately too computationally demanding for use in our 
simulation study. However, this impacts all methods equally and therefore should not affect the 
comparison of the results. 
In conclusion, the choice of the appropriate method(s) to handle partially observed confounders when 
using MSMs must rely on a careful consideration of the reasons for missingness and whether 
missingness modifies the existing relationships among observed data. Although MI outperforms the 
other approaches when data are missing at random, we presented two scenarios, encountered in 
routinely collected data, where MI leads to biased estimates of the treatment effect estimates but 
LOCF and the MPA might be suitable alternatives. We end by noting that any analysis using data with 
some missing values inevitably relies on some assumptions about the missingness mechanisms or 
missingnesss patterns, and that these assumptions are often not made explicit. We therefore 
encourage researchers to clearly describe the assumptions under which their primary analysis is valid, 
and to perform sensitivity analyses to assess robustness of their results to departures from these 
postulated missingness mechanisms. 
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 Table 1. Summary of findings 
Mechanism Complete cases 
Last 
observation 
carried 
forward 
Missing 
pattern 
approach 
Multiple 
imputation 
Inverse 
probability of 
missingness 
weighting 
MCAR     
MAR      
A,L     
A,L,Y     
A,L,V     
Constant     
Differential     
Red crosses indicate biased methods, green ticks indicates unbiased methods 
 
 
  
Figure 1. DAG representing the associations between simulated variables. 
L1,L2 are the two time-varying confounders, A is the time-varying treatment, Y is the continuous outcome, V is a time-
invariant independent risk factor. 
  
Figure 2. DAGs representing the scenarios in which missing values are missing completely at random (MCAR), 
missing at random (MAR) given the confounders and the treatment (MAR|A,L), given the confounders, the 
treatment and the outcome (MAR|A,L,Y) and given the confounders, the treatment and the independent risk 
factor (MAR|A,L,V). A DAG the scenario in which missingness occurs when the confounder value has remained 
unchanged since the previous measurement (Constant). The double arrow indicates that if there is no change in 
the confounder values from the previous time-point. A DAG also presents the scenario in which missingness 
depends on the treatment and confounders (Differential) but the association between the missing value and the 
subsequent treatment allocation does no longer exist. The confounder only contributes to the treatment 
allocation decision when observed. 
L1,L2 are the two time-varying confounders, A is the time-varying treatment, Y is the outcome, V is an independent risk factor 
and R1 and R2 are the missingness indicators at k=1 and k=2, respectively. 
 
   
Figure 3. Absolute bias of the treatment effect estimate at k=0, k=1 and k=2 on full data and following the use 
of different missing data approach under the missing completely at random (MCAR), Constant and Differential 
missingness mechamisms, according . N=10000. 
CC: complete cases; LOCF: last observation carried forward; MPA: missing pattern approach; MI: multiple imputation; 
IPMW: inverse probability of missingness weighting. For multiple imputation, 10 imputed datasets were generated. 
  
 
  
Figure 4. Absolute bias of the treatment effect estimate at k=0, k=1 and k=2 on full data and following the use of 
different missing data approach under 3 scenarios of data missing at random: missing at random given the 
covariates and the treatment (MAR|A,L), given the covariates, the treatment and the outcome (MAR|A,L,Y) and 
given the covariates, the treatment and the independent risk factor (MAR|A,L,V). N=10000. 
CC: complete cases; LOCF: last observation carried forward; MPA: missing pattern approach; MI: multiple imputation; IPMW: 
inverse probability of missingness weighting. For multiple imputation, 10 imputed datasets were generated. 
  
Figure 5: Results of the illustrative example. 
  
APPENDICES 
A1- The potential outcome framework and causal inference in single-time studies 
Causal inference is often formalised using the potential outcomes framework (1), initially developed 
in the context of randomised experiments. In a simple setting in which one is interested in estimating 
the causal effect of a binary treatment A on an outcome Y measured at a single time-point, the causal 
treatment effect is defined as the difference between the two potential outcomes YA=0 and YA=1. These 
are the outcomes that would have been observed had the population been treated versus not. 
 
Three assumptions are usually made to consistently estimate the causal effect of a treatment: (i) no 
interference, (ii) consistency, and (iii) conditional exchangeability. Assumption (i) means that the 
potential outcome values for a given patient are not affected by the treatment values of other 
patients. Assumption (ii) implies that a patient has only one possible potential outcome value for each 
treatment under study and assumption (iii) ensures that there are no unmeasured confounders. If 
these assumptions hold, a multivariable regression model may allow the estimation of an unbiased 
conditional causal treatment effect, provided the model is correctly specified. More advanced 
statistical techniques, such as inverse-probability-of-treatment weighting (IPTW) may be used to 
estimate marginal causal effects. The validity of IPTW relies on the additional assumption of positivity 
(2), meaning that every patient has a non-null probability of receiving either treatment. IPTW aims to 
create a pseudo-population in which the treatment is independent of the confounders, analogous to 
the situation achieved by randomising the treatment in a trial, by weighting the patients by the inverse 
of their probability of receiving the treatment they actually received. This probability  is derived from 
the propensity score (3) and can easily be estimated from the data using a logistic regression model. 
Both multivariable regression and IPTW are valid approaches to estimate causal effects (conditional 
and marginal, respectively) in a simple setting of a single time-point. However, challenges arise when 
treatment and confounder values vary over time. 
 
A2- Estimating the weights of a marginal structural model 
Suppose there are K+1 measurement occasions, from k=0 (baseline) to the study end (k=K). Let A be 
a binary treatment, with Ak representing its level at time k (k=0,…,K) and ?̅?𝑘the treatment history until 
time k. Lk is a vector of confounders measured at time k. We assume that once a patient receives the 
treatment (A=1), they remain under treatment until the end of follow-up (k=K) where the outcome Y 
is measured. We are interested in the estimation of 𝐸(𝑌?̅?), the value of the outcome that would have 
been observed had all subjects received treatment history  a̅. or contrasts of these quantities. For 
example, in our simulation study (Section 4 and 5), we estimate the effect of treatment initiation at 
each time-point. 
 
To estimate these quantities, the weights of the MSM are defined as the patient’s probability of 
receiving their own treatment history given their health history. The stabilized weight for patient i 
(i=1,…n)  is defined as: 
𝑠𝑤𝑖 =
∏ 𝑃(𝐴𝑘=𝑎𝑘𝑖|
𝐾
𝑘=0 ?̅?𝑘−1=?̅?(𝑘−1)𝑖)
∏ 𝑃(𝐴𝑘=𝑎𝑘𝑖|
𝐾
𝑘=0 ?̅?𝑘−1=?̅?(𝑘−1)𝑖,?̅?𝑘=𝑙?̅?𝑖)
,                                                           (1) 
where k=1,…,K is the kth time-point, Ak the treatment received at time k, ?´?𝑘the treatment history until 
time k, Lk the covariates values at time k and ?´?𝑘the covariates history until time k. Stabilized weights 
are preferred to standard weights (i.e. weights computed with 1 at the numerator), because they 
reduce the variability in treatment probabilities that may happen when some covariates are strong 
predictors of treatment. In practice, both the numerator and denominator can be estimated using 
pooled logistic regression, not including and including confounder history, respectively. In pooled 
logistic regression, each person-time interval is considered as an observation. This pooled logistic 
regression model must include the confounders and their relevant interactions to ensure the 
distributions of confounders are balanced between treatment groups in the weighted pseudo-
population at each time-point. 
 
A3- Rubin’s rules to combine treatment effect estimates after multiple imputation 
Multiple imputation of partially observed datasets leads to the generation of M complete datasets 
which are then analysed independently to produce M estimates 𝜃𝑘, (k = 1,…, M) of 𝜃, the vector of 
the parameters of interest (the regression coefficients for A0,…,At in our setting) and their associated 
variance matrix Wk. Then, 𝜃𝑘and Wk, are combined across the M imputed datasets following Rubin’s 
rules in order to obtain an overall estimate and its variance, accounting for the noise introduced by 
the random elements of the imputation. These rules state that the overall estimate 𝜃𝑀𝐼  and its 
estimated variance 𝑉𝑎?̂?(𝜃𝑀𝐼), are (4): 
?̂?𝑀𝐼 =
1
𝑀
∑ ?̂?𝑘
𝑀
𝑘=1
,                         𝑉𝑎?̂?(?̂?𝑀𝐼) = 𝑾 + (1 +
1
𝑀
  ) 𝑩, 
where W is the within-imputation covariance matrix, reflecting the variability in the estimates of the 
parameters of interest within each imputed dataset and B is the between-imputation covariance 
matrix, reflecting how missing data impacts the variability in the estimates. These two variance 
components are estimated as: 
  𝑾 =
1
𝑀
∑ 𝑾𝒌
𝑀
𝑘=1
,                    𝑩 =
1
𝑀 − 1
  ∑( ?̂?𝑘
𝑀
𝑘=1
−  ?̂?𝑀𝐼)
2. 
Because the confounders only enter the first stage of the MSM process, it may be tempting to 
combine the weights across imputed datasets, rather than combining the final treatment effect 
estimates. However, this approach is known to provide biased estimates (5). 
 
A4- Estimation of the missingness weights 
IPMW is very similar to IPTW introduced in section 2. Thus, weights are estimated using, for 
instance, equation (1) (Appendix A1), but using Rk, the missingness indicator at time k (Rk=1 for 
complete cases and Rk=0 if at least one confounder has a missing value at time k). Under MCAR and 
MAR mechanisms, IPMW can allow the estimation of unbiased treatment effect estimates if the 
weight model is correctly specified (i.e. includes all the predictors of missingness in the correct 
functional form). The individual’s missingness weights at time t are the probabilities of being a 
complete case up to that time. 
 
A5- Design of the simulation study 
Aims 
We performed a simulation study (i) to illustrate the impact on bias of violations of the assumptions 
required for each method to be valid, and the relative precision of these methods when the 
assumptions hold and (ii) to highlight existing challenges in their implementation in practice. 
Data-generating mechanisms 
Data were simulated to mimic an observational study, looking at the effect of a time-varying binary 
treatment on a continuous outcome, in the presence of time-varying confounding. Figure 1 presents 
a causal diagram illustrating the association between simulated variables. There are three 
measurement occasions, indexed by k=0,1,2. The continuous outcome was measured at the end of 
follow-up (k=2). Two time-varying confounders (one binary, L1, and one continuous, L2) were 
measured at baseline (k=0) and at two subsequent visits (k=1 and k=2) and one independent risk factor 
was measured at baseline only. The first treatment prescription was dependent on the baseline value 
of these 3 variables. The treatment prescription was then updated based on the current values of the 
two time-varying confounders and treatment history, creating a treatment-confounder feedback loop. 
For simplicity, we assumed that after treatment initiation, patients remained under treatment. The 
two time-varying confounders were fully observed at baseline, but were partially observed at the two 
subsequent visits. Patients could have either none, one or the two confounder values missing at visits 
2 and 3. Missingness was arbitrary (i.e non-monotone); a patient could have a missing value at k=1 
but a measured one at k=2. For a full understanding of the data-generating mechanisms, the R code 
to generate the data is provided as a supplementary file. 
Under each scenario, around 40% of missing date were present at time 2 and 3, leading to a proportion 
of complete cases for all time-points of about 40%. 
Methods 
Treatment effects estimates were obtained via MSM with IPTW as described in Section 3.2.5. At time-
point k (k=0,1,2), inverse-probability-of-treatment weights were estimated using a logistic regression 
model with the treatment received at time t as the outcome and the two confounders L1 and L2 at that 
time-point as predictors. Only participants untreated at the previous time-point contributed to the 
estimation of the weights since participants remain under treatment once they have initiated it. 
Consequently, individual weights stayed constant after initiation. The final weights used for the 
analysis of the primary outcome were the product of the weights up to the time of initiation or up to 
time 2, whichever occurred first. The outcome model was a weighted linear regression model 
including binary treatment indicators at the three time-points.  
We compared the following methods to handle missing data: 
- CC analysis: the parameters of the MSM are estimated using complete cases only, that is 
patients with a measurement available for each of the two time-varying confounders at each 
of the three time points. 
- LOCF: when a patient has a missing confounder value at time k, it is imputed by the most 
recent value observed for that confounder. These singly-imputed values are then treated as if 
they were the observed values; thus, the treatment effect estimates are obtained using a 
MSM from this single imputed dataset. 
- MI: missing confounders values are imputed 10 times using multiple imputation by chained 
equations. The imputation model includes the treatment indicator and confounder values at 
the three time-points, as well as the independent risk factor and the outcome. The MSM is 
fitted in each imputed dataset and the 10 treatment effect estimates are pooled using Rubin’s 
rules. 
- MPA: at times k=2 and k=3, missing data could occur on L1 or L2, leading to 4 missingness 
patterns at each of these time-points. A different weight model is used within each pattern, 
including only the variables fully observed in that pattern. Therefore, weights are estimated 
for every patient based on available information, and the analysis model is fitted on the entire 
original sample. 
- IPMW: the weights for being a complete case are estimated at each time-point. At baseline 
(k=0), there is no missing data, so the weight is 1 for everyone. Then, for k=2 and k=3, the 
weights are estimated as follows: first, a logistic regression model is fitted separately for each 
time-point. The outcome is the binary missingness indicator at that time-point, and the 
predictors are the independent risk factor, and the treatment and confounders history. The 
weights at the 3 time-points are then multiplied together to obtain an overall weight for being 
a complete case, itself multiplied by the overall treatment weight (estimated as in the CC 
analysis). In the second stage (the analysis model to obtain the MSM parameters), complete 
cases were re-weighted using the pooled weights (instead of the treatment weights). 
Estimands 
The three estimands of interest were the causal mean differences in the continuous outcome between 
treated and untreated participants at time k: 𝜃0 is the direct effect of the treatment A0, unmediated 
by A1 and A2. Similarly, 𝜃1 is the direct effect of A1, unmediated by A2 and 𝜃2 is the direct effect of A2. 
Sample size and number of simulations 
The sample size was 10,000 in each generated dataset and 5000 replications were used. 
Performance measures 
The performance of the five methods was assessed using the following measure: 
 Bias of the treatment effect estimate at each time point k (k=0,1,2): 𝐵𝑘 = 𝐸(𝜃𝑘) − 𝜃𝑘 
estimated as: 
1
5000
∑ 𝜃𝑘𝑖
5000
1 − 𝜃𝑘, where 𝜃𝑘 is the true value of the treatment effect at time 
k and 𝜃𝑘𝑖 the estimate of the treatment effect in the i
th simulated dataset (i=1,…,5000). 
 The empirical standard error of the treatment effect estimate at time k: 𝑆𝐸𝑘 = √𝑉𝑎𝑟(𝜃), 
estimated from the data as: √
1
4999
∑ (𝜃𝑘𝑖 − 𝜃𝑘)
25000
𝑖=1 , where 𝜃𝑘 is the average treatment 
effect at time k across the 5000 simulated datasets. 
 The coverage rate, defined as the proportion of 95% confidence intervals containing the true 
value of the treatment effect. 
The Monte-Carlo standard errors for these measures were also computed, as suggested by Morris et 
al. (6). All simulations were performed using R 3.5.1. The mice package (7) was used for multiple 
imputation using chained equations and the package Survey was used to conduct the weighted linear 
regression analysis (8). 
 
TABLES 
Table A1. Absolute bias and coverage rate (%) before the generation of missing values, for 
unadjusted, covariate adjusted and MSM analyses. 
Method 
A0 A1 A2 
Bias Coverage Bias Coverage Bias Coverage 
Unadjusted 0.331 9.6 -0.187 61.6 0.462 0.0 
Multivariable adjustment -0.229 29.1 -0.592 0.0 0.003 94.8 
MSM 0.000 97.2 0.001 97.4 0.000 97.9 
n=10000. The unadjusted analysis does not account for covariates other than treatment history. With multivariable 
adjustment, confounders at each time point are included in the outcome model. MSM: marginal structural model. 5000 
simulations were performed. The maximum Monte-Carlo standard error was 0.002 for the bias and 0.005 for the coverage 
rate. 
 
Table A2. Absolute bias and coverage rate (%) for the 5 methods to handle missing data in each 
scenario considered at time 0. 
Scenario 
CC LOCF MPA MI IPMW 
Bias Coverage Bias Coverage Bias Coverage Bias Coverage Bias Coverage 
MCAR -0.003 97.6 0.000 97.5 -0.030 96.3 -0.001 97.3 -0.004 96.4 
MAR|AL 0.010 97.2 0.004 97.2 -0.029 96.3 0.000 97.0 0.000 96.6 
MAR|ALY -0.234 36.3 0.099 88.8 0.694 0.0 0.002 97.1 -0.245 36.3 
MAR|ALV -0.060 95.5 0.009 97.7 -0.034 96.5 0.000 97.7 -0.008 96.4 
Constant -0.074 95.7 0.000 97.1 -0.046 95.5 -0.045 95.8 -0.098 93.2 
Differential 0.006 97.3 -0.013 97.3 -0.002 97.0 -0.007 97.3 -0.005 96.9 
CC: complete cases; LOCF: last observation carried forward; MPA: missing pattern approach; MI: multiple imputation; IPMW: 
inverse probability of missingness weighting. The initial sample size was n=1000. After introduction of missing data, the 
average number of complete cases varied between n=4096 and n=5698, depending on the scenario. For multiple imputation, 
10 imputed datasets were generated. 5000 simulations were performed. The maximum Monte-Carlo standard error was 
0.002 for the bias and 0.005 for the coverage rate. 
 
Table A3. Absolute bias and coverage rate (%) for the 5 methods to handle missing data in each 
scenario considered at time 1. 
Scenario 
CC LOCF MPA MI IPMW 
Bias Coverage Bias Coverage Bias Coverage Bias Coverage Bias Coverage 
MCAR 0.005 96.9 -0.074 93.7 -0.036 96.1 -0.001 97.4 0.006 96.3 
MAR|AL -0.043 97.0 -0.096 89.8 -0.055 95.2 -0.003 97.1 -0.005 97.0 
MAR|ALY -0.540 0.1 -0.093 92.6 -0.404 25.4 -0.002 98.1 -0.485 1.9 
MAR|ALV -0.089 94.7 -0.085 91.8 -0.039 96.0 -0.001 97.0 -0.004 96.8 
Constant 0.012 97.9 0.000 97.4 -0.072 93.5 -0.021 97.1 -0.100 94.4 
Differential -0.032 97.5 -0.009 97.3 0.003 96.9 0.045 96.0 0.006 97.1 
CC: complete cases; LOCF: last observation carried forward; MPA: missing pattern approach; MI: multiple imputation; IPMW: 
inverse probability of missingness weighting. The initial sample size was n=1000. After introduction of missing data, the 
average number of complete cases varied between n=4096 and n=5698, depending on the scenario. For multiple imputation, 
10 imputed datasets were generated. 5000 simulations were performed. The maximum Monte-Carlo standard error was 
0.002 for the bias and 0.005 for the coverage rate. 
Table A4. Absolute bias and coverage rate (%) for the 5 methods to handle missing data in each 
scenario considered at time 2. 
Scenario 
CC LOCF MPA MI IPMW 
Bias Coverage Bias Coverage Bias Coverage Bias Coverage Bias Coverage 
MCAR 0.000 98.1 0.100 80.2 0.094 82.8 0.002 97.9 0.000 97.0 
MAR|AL 0.002 98.1 0.122 71.3 0.115 75.6 0.004 97.7 0.002 97.2 
MAR|ALY -0.547 0.0 0.000 98.7 -0.437 0.0 0.002 98.3 -0.663 0.0 
MAR|ALV -0.002 97.9 0.104 79.3 0.103 79.7 0.001 97.8 -0.003 96.8 
Constant 0.001 98.1 0.001 97.8 0.165 49.9 0.095 83.8 0.001 97.6 
Differential -0.004 97.9 0.034 96.2 0.001 96.8 -0.048 94.9 -0.003 96.9 
CC: complete cases; LOCF: last observation carried forward; MPA: missing pattern approach; MI: multiple imputation; IPMW: 
inverse probability of missingness weighting. The initial sample size was n=1000. After introduction of missing data, the 
average number of complete cases varied between n=4096 and n=5698, depending on the scenario. For multiple imputation, 
10 imputed datasets were generated. 5000 simulations were performed. The maximum Monte-Carlo standard error was 
0.002 for the bias and 0.005 for the coverage rate. 
  
 Table A5- Mean squared error of the mean differences for the different methods. 
  A0 A1 A2 
  Full CC LOCF MPA MI IPMW Full CC LOCF MPA MI IPMW Full CC LOCF MPA MI IPMW 
MCAR 0.009 0.023 0.009 0.010 0.009 0.025 0.011 0.028 0.016 0.013 0.012 0.030 0.005 0.013 0.015 0.014 0.006 0.014 
MARAL 0.009 0.016 0.009 0.010 0.010 0.019 0.011 0.027 0.020 0.015 0.012 0.028 0.005 0.014 0.020 0.019 0.006 0.016 
MARALY 0.009 0.063 0.019 0.492 0.009 0.070 0.010 0.303 0.019 0.175 0.011 0.248 0.005 0.306 0.005 0.196 0.005 0.447 
MARALV 0.009 0.020 0.009 0.010 0.009 0.020 0.011 0.034 0.018 0.013 0.012 0.033 0.005 0.014 0.016 0.016 0.006 0.020 
Constant 0.009 0.028 0.009 0.011 0.011 0.035 0.011 0.026 0.011 0.016 0.012 0.040 0.005 0.012 0.005 0.033 0.015 0.014 
Differential 0.009 0.017 0.010 0.010 0.010 0.019 0.011 0.026 0.012 0.013 0.014 0.029 0.006 0.015 0.007 0.006 0.008 0.018 
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Table A6. Description of the exposure groups at baseline (illustrative example) 
  Non observant Observant 
Standardised mean 
difference (%) 
  n*=204 n*=1084   
Female    70 (34.3)    335 (30.9)  7.3 
Age (mean (SD)) 56.02 (13.33) 58.26 (12.97) 17.1 
Sedentary    29 (14.3)    184 (17.0)  7.5 
BMI (mean (SD)) 32.12 (6.48) 32.19 (6.34) 1.1 
Depression score** (mean (SD))  4.55 (3.91)  4.35 (3.87) 5.2 
Frequency of urination>1    87 (72.5)    405 (77.1)  10.7 
* 153 patients had missing exposure value; ** Depression score was calculated using the Pichot depression 
scale 
 
Table A7. Estimated mean differences in sleepiness scores for the different analysis methods. 
Analysis 
n 
  Mean difference (95% confidence interval) 
method   t=1 t=2 t=3 
Unadjusted 897  -0.684 [-1.582;-0.213] 0.152 [-0.868;1.171] -1.324[-2.278;-0.370] 
IPTW      
Complete cases 266  -0.257 [-2.013;1.500] 0.268 [-2.203;2.739] -0.072 [-2.407;2.263] 
LOCF 521  -0.537 [-2.001;0.926] -0.125 [-2.012;1.762] -0.373 [-1.834;1.089] 
Multiple imputation 1169  -0.804 [-1.768;0.161] -0.128 [-1.293;1.036] -1.194 [-2.200;-0.188] 
IPMW 266  -0.381 [-2.235;1.473] 0.116 [-2.371; 2.601] 0.050 [-2.223;2.323] 
MPA     NA NA NA 
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